Treatment of Hodgkin's granuloma, chronic lymphatic leukaemia, polycythaemia vera, and other reticuloses with triethylenethiophosphoramide.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000628:therapy*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D009369:Neoplasms; D020135:Peptide Nucleic Acids; D011087:Polycythemia Vera / Q000628:therapy*; D012509:Sarcoma; D013852:Thiotepa
D000970:Antineoplastic Agents; D020135:Peptide Nucleic Acids; D013852:Thiotepa
CYTOTOXIC DRUGS/therapeutic use; HODGKINS DISEASE/therapy; POLYCYTHEMIA VERA/therapy; SARCOMA, RETICULUM CELL/therapy